1. Home
  2. RNW vs HRMY Comparison

RNW vs HRMY Comparison

Compare RNW & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$4.83

Market Cap

1.7B

Sector

Utilities

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$29.34

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
HRMY
Founded
2011
2017
Country
United Kingdom
United States
Employees
4336
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RNW
HRMY
Price
$4.83
$29.34
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$7.00
$46.70
AVG Volume (30 Days)
823.4K
605.9K
Earning Date
02-16-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
2.71
Revenue
N/A
$868,453,000.00
Revenue This Year
N/A
$19.75
Revenue Next Year
$11.50
$12.88
P/E Ratio
$14.63
$10.72
Revenue Growth
N/A
21.51
52 Week Low
$4.39
$25.52
52 Week High
$8.24
$40.87

Technical Indicators

Market Signals
Indicator
RNW
HRMY
Relative Strength Index (RSI) 44.41 56.76
Support Level $4.39 $25.92
Resistance Level $5.58 $30.96
Average True Range (ATR) 0.14 0.82
MACD 0.03 0.42
Stochastic Oscillator 71.03 91.72

Price Performance

Historical Comparison
RNW
HRMY

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: